The effect of landiolol hydrochloride for primary lung cancer patients with tachyarrhythmia in the perioperative period
- Conditions
- Primary lung cancer
- Registration Number
- JPRN-UMIN000023045
- Lead Sponsor
- Department of Thoracic Surgery, Kitasato University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
Patient corresponding to the contraindication of landiolol hydrochloride 1) Patients with cardiogenic shock 2) Patients with diabetic ketoacidosis or metabolic acidosis 3) Patients with auriculoventricular block(out of 2nd degree) or bradyarrhythmia including sick sinus syndrome 4)Patients with right cardiac failure from pulmonary hypertension 5) Patients with congestive cardiac failure 6) Patients with untreated phaeochromocytoma 7) Patients with a previous history of hypersensitivity to components of landiolol hydrochloride 8) Patients with bronchial asthma 9) Patient with sick sinus syndrome(Including a pacemaker implantation) 10) Patient who is pregnant woman also possibility of pregnancy or nursing mother 11) Patient who is judged as inappropriate by doctor in attendance
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the tachyarrhythmia incidence up to postoperative 72 hours between landiolol hydrochloride administration group and the non-administration group
- Secondary Outcome Measures
Name Time Method